Michael Fuchs
Overview
Explore the profile of Michael Fuchs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
332
Citations
6843
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fuchs M
Philos Trans R Soc Lond B Biol Sci
. 2025 Feb;
380(1919):20230304.
PMID: 39976416
Shape parameters, e.g. balance indices, of evolutionary trees have been extensively studied under the Yule model in phylogenetics. Independently, many of the same parameters have also been studied for random...
2.
Kuhn D, Hermanns R, Fuchs M, Schussler N, Torizin J, Aga J, et al.
Sci Total Environ
. 2025 Feb;
968:178807.
PMID: 39970554
Deep-seated landslides pose a potential threat to coastal settlements, shipping routes, and the natural environment of the polar regions. However, the occurrence, dynamics and impact of such landslides under a...
3.
Kakiyama G, Bai-Kamara N, Rodriguez-Agudo D, Takei H, Minowa K, Fuchs M, et al.
J Lipid Res
. 2025 Feb;
66(3):100757.
PMID: 39952566
Effect of liver specific oxysterol 7α-hydroxylase (CYP7B1) overexpression on the Western diet (WD)-induced metabolic dysfunction-associated steatotic liver disease (MASLD) progression was studied in mice. Among various hepatic genes impacted during...
4.
Bajaj J, Fagan A, Gavis E, Sterling R, Gallagher M, Lee H, et al.
J Hepatol
. 2025 Jan;
PMID: 39800192
Background: Preventing hepatic encephalopathy (HE) recurrence in cirrhosis, which is associated with an altered gut-liver-brain axis, is an unmet need. Fecal microbiota transplantation (FMT) is beneficial in phase-1 studies, but...
5.
Niezen S, Morgan T, Scott D, Yakovchenko V, Patton H, Spoutz P, et al.
Am J Gastroenterol
. 2025 Jan;
PMID: 39774063
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD), an increasing public health concern, remains challenging to diagnose and risk-stratify. We assessed the (i) prevalence of MASLD risk factors among veterans in...
6.
Zeng J, Zhao D, Way G, Fagan A, Fuchs M, Puri P, et al.
JCI Insight
. 2025 Jan;
10(4).
PMID: 39773539
Cirrhosis, the end-stage of liver disease, progresses through altered gut-liver axis and microbial change. Here we show that intestinal mucosal mitochondrial oxidative phosphorylation, which affects intestinal barrier worsens with cirrhosis...
7.
Maurer S, Fuchs M, Brenner R, Riegger J
Heliyon
. 2024 Dec;
10(22):e40368.
PMID: 39624277
Joint injuries and consequent oxidative stress is a high-risk factor for developing post-traumatic osteoarthritis (OA). While antioxidative therapy using N-acetylcysteine (NAC) has cell- and chondroprotective effects following cartilage injury, it...
8.
Harris S, Al-Yassin S, Chaudhari R, Gallagher M, Davis B, Malpaya Z, et al.
Liver Transpl
. 2024 Nov;
PMID: 39526887
Alcohol use disorder is prevalent within the Veterans Health System, especially in patients being seen in hepatology clinics, and needs a point-of-care strategy. A brief alcohol intervention based on AUDIT-C...
9.
Karbysheva S, Morovic P, Bellova P, Berger M, Stiehler M, Meller S, et al.
Clin Chem Lab Med
. 2024 Sep;
PMID: 39321552
Objectives: The performance of synovial fluid biomarker D-lactate to diagnose septic arthritis (SA) and differentiate it from crystal-induced arthritis (CA), other non-infectious rheumatic joint diseases (RD) and osteoarthrosis (OA) was...
10.
Gessner S, Meuret S, Fuchs M, Tretbar K
Laryngorhinootologie
. 2024 Sep;
PMID: 39227011
Objective: Despite cochlear implantation, CI users experience difficulties in challenging listening situations. In German-speaking countries, there are no interventions to promote specific coping strategies for such situations. The present study...